Outcomes in Valve-in-Valve Transcatheter Aortic Valve Implantation.
van Nieuwkerk AC, Santos RB, Fernandez-Nofrerias E, Tchétché D, de Brito FS Jr, Barbanti M, Kornowski R, Latib A, D'Onofrio A, Ribichini F, Mainar V, Dumonteil N, Baan J, Abizaid A, Sartori S, D'Errigo P, Tarantini G, Lunardi M, Orvin K, Pagnesi M, Larraya GL, Ghattas A, Dangas G, Mehran R, Delewi R.
van Nieuwkerk AC, et al. Among authors: ghattas a.
Am J Cardiol. 2022 Jun 1;172:81-89. doi: 10.1016/j.amjcard.2022.02.028. Epub 2022 Mar 26.
Am J Cardiol. 2022.
PMID: 35351288
Free article.
Patients with ViV-TAVI were treated with self-expandable valves (n = 162) and balloon-expandable valves (n = 94). Thirty-day major bleeding was less frequent in patients with self-expandable valves (3% vs 13%, odds ratio 5.12, 95% CI 1.42 to 18.52, p = 0.01). ...
Patients with ViV-TAVI were treated with self-expandable valves (n = 162) and balloon-expandable valves (n = 94). Thirty-day m …